Urufarma’s new industrial complex ratifies Uruguay as a benchmark for the pharmaceutical industry in the region

The company Urufarma recently inaugurated a new industrial plant for the production of oncological products to increase its production capacity. This is evidence of Uruguay’s continuous expansion of its pharmaceutical and health sector in recent years.

The new complex, located a few kilometers from Carrasco Airport, is intended to produce oncology drugs. It includes a quality control laboratory, three production plants, and offices. One of the plants will be dedicated to the manufacture of oncology drugs.

The start-up investment was almost US$ 40 million.

The new industrial plant increases production capacity and complies with international World Health Organization (WHO) guidelines for the pharmaceutical industry, which are applied in Uruguay through the Ministry of Public Health.

In addition, Urufarma, a leader in scientific innovation, has a historical commitment to the environment and constantly carries out exhaustive analyses of alternatives, opting for the most efficient in the environmental equation and prioritizing the sustainability and efficiency of its wastewater treatment system.

The inauguration of the new oncological plant was attended by the President of Uruguay, Luis Lacalle Pou, accompanied by the Vice President, Beatriz Argimón; the Secretary of the Presidency, Rodrigo Ferrés; the Ministers of Industry, Energy, and Mining, Elisa Facio, and Public Health, Karina Rando. Also in attendance were the mayor of Canelones, Marcelo Metediera, and the general manager of the pharmaceutical company, Fernando Moreira, among other national and departmental authorities.

Facio pointed out that the production unit integrates the areas of technology, innovation, energy efficiency, and environmental care, which are the main lines of work of the ministry he heads. He also valued that the project places the country as a reference in the region’s pharmaceutical industry and entails expanding production capacity and demand for skilled labor.

Pharma, an expanding sector

Uruguay’s health and pharmaceutical sector has been expanding remarkably in recent years. In this sense, the country has a series of strengths that support its value proposition for attracting investment and developing exports focused on Life Sciences, including the pharmaceutical and medical device industry, animal health, and biotechnology-based developments.

Its reliability, stability, institutional strength, quality of life, and proven track record as a business hub for multinational and multi-Latin pharmaceutical companies, in addition to its access to qualified talent and tax incentives, were critical to this growth.